TR200301553A1 - İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar - Google Patents
İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlarInfo
- Publication number
- TR200301553A1 TR200301553A1 TR2003/01553A TR200301553A TR200301553A1 TR 200301553 A1 TR200301553 A1 TR 200301553A1 TR 2003/01553 A TR2003/01553 A TR 2003/01553A TR 200301553 A TR200301553 A TR 200301553A TR 200301553 A1 TR200301553 A1 TR 200301553A1
- Authority
- TR
- Turkey
- Prior art keywords
- active ingredient
- pharmaceutical formulations
- formulations containing
- oral pharmaceutical
- new oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
Bu buluş irbesartan etken maddesini içeren ve bu etken maddenin oral yolla alınmasını sağlayan yeni farmasötik dozaj formlarını hazırlamak için geliştirilen yeni yöntem ile ilgilidir. Geliştirilen bu formülasyon ile irbesartanın dissolüsyon özelliklerine üstünlük kazandırılmıştır.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2003/01553A TR200301553A1 (tr) | 2003-09-18 | 2003-09-18 | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
PCT/TR2004/000040 WO2005025566A1 (en) | 2003-09-18 | 2004-09-16 | Oral pharmaceutical formulations containing the active ingredient irbesartan |
EP04775700A EP1670461A1 (en) | 2003-09-18 | 2004-09-16 | Oral pharmaceutical formulations containing the active ingredient irbesartan |
TR2006/01092T TR200601092T1 (tr) | 2003-09-18 | 2004-09-16 | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2003/01553A TR200301553A1 (tr) | 2003-09-18 | 2003-09-18 | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200301553A1 true TR200301553A1 (tr) | 2005-10-21 |
Family
ID=34311482
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2003/01553A TR200301553A1 (tr) | 2003-09-18 | 2003-09-18 | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
TR2006/01092T TR200601092T1 (tr) | 2003-09-18 | 2004-09-16 | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2006/01092T TR200601092T1 (tr) | 2003-09-18 | 2004-09-16 | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1670461A1 (tr) |
TR (2) | TR200301553A1 (tr) |
WO (1) | WO2005025566A1 (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1806130T1 (sl) * | 2006-01-09 | 2010-06-30 | KRKA@@d@d@@@Novo@mesto | Trden farmacevtski sestavek ki obsega irbesartan |
EP1923053A1 (en) | 2006-09-27 | 2008-05-21 | Novartis AG | Pharmaceutical compositions comprising nilotinib or its salt |
CN101011393B (zh) * | 2007-02-16 | 2010-10-06 | 广州柏赛罗药业有限公司 | 厄贝沙坦胃内滞留型缓释药物组合物 |
DE102007055341A1 (de) * | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
PT2065035E (pt) | 2007-11-28 | 2010-10-04 | Lesvi Laboratorios Sl | Formulações farmacêuticas contendo irbesartan |
WO2011141783A2 (en) | 2010-04-13 | 2011-11-17 | Micro Labs Limited | Pharmaceutical composition comprising irbesartan |
DE102011108762A1 (de) * | 2011-07-28 | 2013-01-31 | Stada Arzneimittel Ag | Verpresste feste pharmazeutische Zusammensetzung, umfassend amorphes partikuläres Valsartan als Wirkstoff |
CN107028912B (zh) * | 2017-05-31 | 2019-03-19 | 珠海润都制药股份有限公司 | 一种厄贝沙坦胶囊的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
TW442301B (en) * | 1995-06-07 | 2001-06-23 | Sanofi Synthelabo | Pharmaceutical compositions containing irbesartan |
US5994348A (en) * | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
FR2831446B1 (fr) * | 2001-10-26 | 2004-03-05 | Sanofi Synthelabo | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
CN1199641C (zh) * | 2002-10-24 | 2005-05-04 | 王登之 | 一种用于治疗高血压的复方厄贝沙坦胶囊 |
-
2003
- 2003-09-18 TR TR2003/01553A patent/TR200301553A1/tr unknown
-
2004
- 2004-09-16 WO PCT/TR2004/000040 patent/WO2005025566A1/en active Application Filing
- 2004-09-16 TR TR2006/01092T patent/TR200601092T1/tr unknown
- 2004-09-16 EP EP04775700A patent/EP1670461A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1670461A1 (en) | 2006-06-21 |
WO2005025566A1 (en) | 2005-03-24 |
TR200601092T1 (tr) | 2006-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
BR0306870A (pt) | Composição farmacêutica oral, e, método para preparar a mesma | |
CY1111458T1 (el) | Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
ATE472551T1 (de) | Tocopherolmodifizierte therapeutische arzneimittelverbindung | |
NO20062051L (no) | Farmasoytisk virkestoffinneholdende formulering med belegg | |
ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
DE50203456D1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TR200301553A1 (tr) | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar | |
NO20062668L (no) | Orale formuleringer av desoxypeganin og anvendelser derav | |
SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
CY1106964T1 (el) | Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους | |
SE0203817D0 (sv) | New composition | |
TR200301552A1 (tr) | Rofekoksib' in yeni oral farmakolojik formülasyonları. | |
EA200700524A1 (ru) | Препараты для перорального применения с эффектом замедленного действия при приеме api вместе с пищей |